Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
CA 2404322 A1 · Owner: Eibl, Hansjorg · Inventors: Eibl, Hansjorg
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to pharmaceutical formulations for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and , diseases caused by arthropods characterised in that they contain an effective mixture of a) at least one phospholipid compound of formula (I) where R1 = a , 16 to 24 C hydrocarbon residue R2, R3 and R4 = independently, H, C1-C5 alkyl C3-C6 cycloalkyl or C1-C5 hydroxyalkyl where two of R2, R3 and R4 together , form a C2-C5 alkylene group optionally substituted with an -O-, -S- or NR5 group, where R5 = H, C1-C5 alkyl, C3-C6 cycloalkyl or C1-C5 hydroxyalkyl and n = a whole number from 2 to 6 as an active ingredient at from 30 to 60 mol % …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 29, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.